|Bid||0.5096 x 1000|
|Ask||0.5129 x 1000|
|Day's Range||0.5001 - 0.5500|
|52 Week Range||0.3510 - 1.6000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
Q2 2020 Mytesi net sales and gross sales were approximately $3.
Company Plans to File Q2 2020 10-Q on August 13, 2020Save the Date: Company to host virtual disease awareness event on October 20, 2020 focused on cancer therapy-related diarrheaSAN FRANCISCO, CA / ACCESSWIRE / August 11, 2020 / Jaguar Health, Inc.
A significant proportion of patients undergoing cancer therapy experience diarrheaSAN FRANCISCO, CA / ACCESSWIRE / August 6, 2020 / Jaguar Health, Inc.